Obstructive sleep apnea and non-alcoholic fatty liver disease: Is the liver another target?

Frontiers in Neurology

Volumn OCT, Issue , 2012, Pages

  Mirrakhimov, Aibek E ^a   Polotsky, Vsevolod ^b  

^a Kyrgyz State Medical Academy   (Kyrgyzstan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Intermittent hypoxia; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Sleep apnea

Indexed keywords

EID: 84869161009     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00149     Document Type: Article

References (166)

1. Angulo, P., Keach, J. C., Batts, K. P., and Lindor, K. D. (1999). Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30, 1356-1362.
2. Aron-Wisnewsky, J., Minville, C., Tord-jman, J., Levy, P., Bouillot, J. L., Bas-devant, A., et al. (2012). Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J. Hepatol. 56, 225-233.
3. Bao, G., Metreveli, N., Li, R., Taylor, A., and Fletcher, E. C. (1997). Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J. Appl. Physiol. 83, 95-101.
4. Baranova, A., Lal, P., Birerdinc, A., and Younossi, Z. M. (2011). Non-invasive markers for hepatic fibrosis. BMC Gastroenterol. 11, 91. doi:10.1186/1471-230X-11-91
5. Barcelo, A., Pierola, J., de la, P. M., Esquinas, C., Fuster, A., Sanchez-de-la-Torre, M., et al. (2011). Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea. Eur. Respir. J. 37, 1418-1423.
6. Bataller, R., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J., et al. (2003). NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest. 112, 1383-1394.
7. Bellentani, S., Saccoccio, G., Masutti, F., Croce, L. S., Brandi, G., Sasso, F., et al. (2000). Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med. 132, 112-117.
8. Ben-Neriah, Y., and Karin, M. (2011). Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat. Immunol. 12, 715-723.
9. Bergamini, C. M., Gambetti, S., Dondi, A., and Cervellati, C. (2004). Oxygen, reactive oxygen species and tissue damage. Curr. Pharm. Des. 10, 1611-1626.
10. Bickel, P. E., Tansey, J. T., and Welte, M. A. (2009). PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim. Biophys. Acta 1791, 419-440.
11. Biddinger, S. B., Almind, K., Miyazaki, M., Kokkotou, E., Ntambi,J. M., and Kahn, C. R. (2005). Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes 54, 1314-1323.
12. Boden, G., She, P., Mozzoli, M., Cheung, P., Gumireddy, K., Reddy, P., et al. (2005). Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 54, 3458-3465.
13. Bonekamp, S., Kamel, I., Solga, S., and Clark,J. (2009). Canimagingmodal-ities diagnose and stage hepatic fibrosis and cirrhosis accurately? J. Hepatol. 50, 17-35.
14. Bonsignore, M. R., Esquinas, C., Barcelo, A., Sanchez-de-la-Torre, M., Paterno, A., Duran-Cantolla, J., et al. (2012). Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur. Respir. J. 39, 1136-1143.
15. Brar, S. S., Kennedy, T. P., Quinn, M., and Hoidal, J. R. (2003). Redox signaling of NF-kappaB by membrane NAD(P)H oxidases in normal and malignant cells. Protoplasma 221, 117-127.
16. Browning, J. D., and Horton, J. D. (2004). Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114, 147-152.
17. Browning,J. D., Szczepaniak,L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., et al. (2004). Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387-1395.
18. Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., et al. (2002). Expanding the natural history of nonalcoholic steato-hepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gas-troenterology 123, 134-140.
19. Cai, D., Yuan, M., Frantz, D. F., Melen-dez, P. A., Hansen, L., Lee, J., et al. (2005). Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11, 183-190.
20. Caldwell, S. H., Oelsner, D. H., Iez-zoni, J. C., Hespenheide, E. E., Battle, E. H., and Driscoll, C. J. (1999). Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29, 664-669.
21. Carlson, J. T., Hedner, J., Elam, M., Ejnell, H., Sellgren, J., and Wallin, B. G. (1993). Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103, 1763-1768.
22. Carmiel-Haggai, M., Cederbaum, A. I., and Nieto, N. (2005). A high-fat diet leads to the progression of nonalcoholic fatty liver disease in obese rats. FASEB J. 19, 136-138.
23. Chin, K., Nakamura, T., Takahashi, K., Sumi, K., Ogawa, Y., Masuzaki, H., et al. (2003). Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am. J. Med. 114, 370-376.
24. Clark, J. M. (2006). The epidemiology of nonalcoholic fatty liver disease in adults. J. Clin. Gastroenterol. 40, S5-S10.
25. Clark, J. M., and Diehl, A. M. (2003). Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 289, 3000-3004.
26. Cohen, P., Miyazaki, M., Socci, N. D., Hagge-Greenberg, A., Liedtke, W., Soukas, A. A., et al. (2002). Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297, 240-243.
27. Copple, B. L., Bai, S., Burgoon, L. D., and Moon, J. O. (2011). Hypoxia-inducible factor-1alpha regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogene-sis. Liver Int. 31, 230-244.
28. Copple, B. L., Bustamante, J. J., Welch, T. P., Kim, N. D., and Moon, J. O. (2009). Hypoxia-inducible factor-dependent productionof profibrotic mediators by hypoxic hepatocytes. Liver Int. 29, 1010-1021.
29. Daltro, C., Cotrim, H. P., Alves, E., de Freitas, L. A., Araujo, L., Boente, L., et al. (2010). Nonalcoholic fatty liver disease associated with obstructive sleep apnea: justa coincidence?Obes. Surg. 20, 1536-1543.
30. Davies, M. N., O'Callaghan, B. L., and Towle, H. C. (2008). Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity. J. Biol. Chem. 283, 24029-24038.
31. Day, C. P., and James, O. F. (1998). Steatohepatitis: a tale of two "hits"? Gastroenterology 114, 842-845.
32. Delarue,J.,and Magnan,C. (2007). Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 10, 142-148.
33. Dentin, R., Benhamed, F., Hainault, I., Fauveau,V., Foufelle,F., Dyck,J. R.,et al. (2006). Liver-specific inhibition of ChREBP improves hepatic steato-sis and insulin resistance in ob/ob mice. Diabetes 55, 2159-2170.
34. Diehl, A. M. (2005). Lessons from animal models of NASH. Hepatol. Res. 33, 138-144.
35. Dimsdale, J. E., Coy, T., Ziegler, M. G., ncoli-Israel, S., and Clausen, J. (1995). The effect of sleep apnea on plasma and urinary catecholamines. Sleep 18, 377-381.
36. Dixon, J. B., Bhathal, P. S., and O'Brien, P. E. (2001). Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121, 91-100.
37. Drager, L. F., Jun, J. C., and Polotsky, V. Y. (2010a). Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract. Res. Clin. Endocrinol. Metab. 24, 843-851.
38. Drager, L. F., Lopes, H. F., Maki-Nunes, C., Trombetta, I. C., Toschi-Dias, E., Alves, M. J., et al. (2010b). The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS ONE 5, e12065. doi:10.1371/journal.pone.0012065
39. Drager, L. F., Li, J., Reinke, C., Bevans-Fonti, S., Jun, J. C., and Polotsky, V. Y. (2011). Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) 19, 2167-2174.
40. Fletcher, E. C. (2001). Invited review: physiological consequences of intermittent hypoxia: systemic blood pressure. J. Appl. Physiol. 90, 1600-1605.
41. Fletcher, E. C., Bao, G., and Miller, C. C. III. (1995). Effect of recurrent episodic hypocapnic, eucapnic, and hypercapnic hypoxia on systemic blood pressure. J. Appl. Physiol. 78, 1516-1521.
42. Fletcher, E. C., Lesske, J., Behm, R., Miller, C. C., Stauss, H., and Unger, T. (1992a). Carotid chemorecep-tors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J. Appl. Physiol. 72, 1978-1984.
43. Fletcher, E. C., Lesske, J., Culman, J., Miller, C. C., and Unger, T. (1992b). Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 20, 612-619.
44. Foretz, M., Pacot, C., Dugail, I., Lemarc-hand, P., Guichard, C., Le, L. X., et al. (1999). ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol. Cell. Biol. 19, 3760-3768.
45. Friedrich-Rust, M., Hadji-Hosseini, H., Kriener, S., Herrmann, E., Sircar, I., Kau, A., et al. (2010). Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur. Radiol. 20, 2390-2396.
46. Gami, A. S., Howard, D. E., Olson, E. J., and Somers,V. K. (2005). Day-night pattern of sudden death in obstructive sleep apnea. N. Engl. J. Med. 352, 1206-1214.
47. Gastaut, H., Tassinari, C. A., and Duron, B. (1966). Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome. Brain Res. 1, 167-186.
48. George, J., Pera, N., Phung, N., Leclercq, I., Yun, H. J., and Farrell, G. (2003). Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J. Hepatol. 39, 756-764.
49. Gude, F., Rey-Garcia, J., Fernandez-Merino, C., Meijide, L., Garcia-Ortiz, L., Zamarron, C., et al. (2009). Serum levels of gamma-glutamyl transferase are associated with markers of nocturnal hypox-emia in a general adult population. Clin. Chim. Acta 407, 67-71.
50. Guilherme, A., Virbasius, J. V., Puri, V., and Czech, M. P. (2008). Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367-377.
51. Haase, V. H. (2009). Pathophysiologi-cal Consequences of HIFActivation: HIF as a modulator of fibrosis. Ann. N. Y. Acad. Sci. 1177, 57-65.
52. Haase, V. H., Glickman, J. N., Socolovsky, M., and Jaenisch, R. (2001). Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. U.S.A. 98, 1583-1588.
53. Hedner, J., Darpo, B., Ejnell, H., Carlson, J., and Caidahl, K. (1995). Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur. Respir. J. 8, 222-229.
54. Henrion, J., Colin, L., Schapira, M., and Heller, F. R. (1997). Hypoxic hepatitis caused by severe hypox-emia from obstructive sleep apnea. J. Clin. Gastroenterol. 24, 245-249.
55. Henrion, J., Schapira, M., Luwaert, R., Colin, L., Delannoy, A., and Heller, F. R. (2003). Hypoxic hepatitis: clinical and hemodynamic studyin 142 consecutive cases. Medicine (Baltimore) 82, 392-406.
56. Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., et al. (2011). Diagnostic accuracy and reliability of ultrasonog-raphy for the detection of fatty liver: a meta-analysis. Hepatology 54, 1082-1090.
57. Hilden, M., Christoffersen, P., Juhl, E., and Dalgaard, J. B. (1977). Liver histology in a "normal" population - examinations of 503 consecutive fatal traffic casualties. Scand. J. Gastroenterol. 12, 593-597.
58. Hoyos, C. M., Killick, R., Yee, B. J., Phillips, C. L., Grunstein, R. R., and Liu, P. Y. (2012). Cardiometa-bolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax. PMID: 22561530. [Epub ahead of print].
59. Iiyori, N., Alonso, L. C., Li, J., Sanders, M. H., Garcia-Ocana,A., O'Doherty, R. M., et al. (2007). Intermittent hypoxia causes insulin resistance in lean miceindependentof autonomic activity.Am. J. Respir. Crit. Care Med. 175, 851-857.
60. Iizuka, K., Bruick, R. K., Liang, G., Hor-ton, J. D., and Uyeda, K. (2004). Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycol-ysis. Proc. Natl. Acad. Sci. U.S.A. 101, 7281-7286.
61. Jaworski, K., Sarkadi-Nagy, E., Duncan, R. E., Ahmadian, M., and Sul, H. S. (2007). Regulation of triglyc-eride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1-G4.
62. Jocken, J. W., and Blaak, E. E. (2008). Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiol. Behav. 94, 219-230.
63. Jouet, P., Sabate, J. M., Maillard, D., Msika, S., Mechler, C., Ledoux, S., et al. (2007). Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study. Obes. Surg. 17, 478-485.
64. Jun, J., and Polotsky, V. Y. (2009). Metabolic consequences of sleep-disordered breathing. ILAR J. 50, 289-306.
65. Jun, J., Savransky, V., Nanayakkara, A., Bevans, S., Li, J., Smith, P. L., et al. (2008). Intermittent hypoxia has organ-specific effects on oxidative stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1274-R1281.
66. Jun, J. C., Drager, L. F., Najjar, S. S., Gottlieb, S. S., Brown, C. D., Smith, P. L., et al. (2011). Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep 34, 1207-1213.
67. Kallwitz, E. R., Herdegen, J., Madura, J., Jakate, S., and Cotler, S. J. (2007). Liver enzymes and histology in obese patients with obstructive sleep apnea. J. Clin. Gastroenterol. 41, 918-921.
68. Kashi, M. R., Torres, D. M., and Harrison, S. A. (2008). Current and emerging therapies in nonalcoholic fatty liver disease. Semin. Liver Dis. 28, 396-406.
69. Kheirandish-Gozal, L., Sans, C. O., Kheirandish, E., and Gozal, D. (2008). Elevated serum aminotrans-ferase levels in children at risk for obstructive sleep apnea. Chest 133, 92-99.
70. Kim,C.W.,Chang,Y.,Sung,E.,Shin,H., and Ryu, S. (2012). Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men. Metabolism 61, 1182-1188.
71. Kim,J. K., Kim,Y. J., Fillmore,J. J., Chen, Y., Moore, I., Lee, J.,et al. (2001). Prevention of fat-induced insulin resis-tancebysalicylate. J. Clin. Invest.108, 437-446.
72. Kleiner, D. E., Brunt, E. M., Van, N. M., Behling, C., Contos, M. J., Cummings, O. W., et al. (2005). Design and validation of a histo-logical scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321.
73. Kohler, M., Pepperell, J. C., Davies, R. J., and Stradling, J. R. (2009). Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial. Respiration 78, 141-146.
74. Kowdley,K.V.,Belt,P.,Wilson,L.A.,Yeh, M. M., Neuschwander-Tetri, B. A., Chalasani, N., et al. (2012). Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 55, 77-85.
75. Lafontan, M., and Langin, D. (2009). Lipolysis and lipid mobilization in human adipose tissue. Prog. Lipid Res. 48, 275-297.
76. Laurent, A., Nicco, C., Tran, V. N., Bor-derie, D., Chereau, C., Conti, F., et al. (2004). Pivotal role of superoxide anion and beneficial effect of antiox-idant molecules in murine steato-hepatitis. Hepatology 39, 1277-1285.
77. Lavie, L., and Polotsky, V. (2009). Cardiovascular aspects in obstructive sleep Apnea syndrome - molecular issues,hypoxia andcytokine profiles. Respiration 78, 361-370.
78. Lehwald, N., Tao, G. Z., Jang, K. Y., Sorkin, M., Knoefel, W. T., and Sylvester, K. G. (2011). Wnt-beta-catenin signaling protects against hepatic ischemia and reperfusion injury in mice. Gastroenterology 141, 707-18, 718.
79. Levy, P., Bonsignore, M. R., and Eckel, J. (2009). Sleep, sleep-disordered breathing and metabolic consequences. Eur. Respir. J. 34, 243-260.
80. Li, J., Bosch-Marce, M., Nanayakkara, A., Savransky, V., Fried, S. K., Semenza, G. L., et al. (2006). Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol. Genomics 25, 450-457.
81. Li, J., Grigoryev, D. N., Ye, S. Q., Thorne, L., Schwartz, A. R., Smith, P. L., et al. (2005a). Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J. Appl. Physiol. 99, 1643-1648.
82. Li, J., Thorne,L. N., Punjabi,N. M., Sun, C. K., Schwartz, A. R., Smith, P. L., et al. (2005b). Intermittent hypoxia induces hyperlipidemia in lean mice. Circ. Res. 97, 698-706.
83. Li, J., Savransky, V., Nanayakkara, A., Smith, P. L., O'Donnell, C. P., and Polotsky, V. Y. (2007). Hyperlipi-demia and lipid peroxidation are dependent ontheseverity of chronic intermittent hypoxia. J. Appl. Phys-iol. 102, 557-563.
84. Li, N., and Karin, M. (1999). Is NF-kappaB the sensor of oxidative stress? FASEB J. 13, 1137-1143.
85. Li, Z. Z., Berk, M., McIntyre, T. M., and Feldstein, A. E. (2009). Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J. Biol. Chem. 284, 5637-5644.
86. Licata, A., Nebbia, M. E., Cabibbo, G., Iacono, G. L., Barbaria, F., Brucato, V., et al. (2009). Hyperferritinemia is a risk factor for steatosis in chronic liver disease. World J. Gastroenterol. 15, 2132-2138.
87. Louis, M., and Punjabi, N. M. (2009). Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J. Appl. Physiol. 106, 1538-1544.
88. Ludwig, J., McGill, D. B., and Lin-dor, K. D. (1997). Review: nonalcoholic steatohepatitis. J. Gastroen-terol. Hepatol. 12, 398-403.
89. Ma, L., Robinson, L. N., and Towle, H. C. (2006). ChREBP-Mlx is the principal mediator of glucose-induced gene expression in the liver. J. Biol. Chem. 281, 28721-28730.
90. Majmundar, A. J., Wong, W. J., and Simon, M. C. (2010). Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40, 294-309.
91. Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B. D., Ye, S. Q., et al. (2005). Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105, 659-669.
92. Manousou, P., Kalambokis, G., Grillo, F., Watkins, J., Xirouchakis, E., Pleguezuelo, M., et al. (2011). Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Liver Int. 31, 730-739.
93. Marshall, N. S., Wong, K. K., Liu, P. Y., Cullen, S. R., Knuiman, M. W., and Grunstein, R. R. (2008). Sleep apnea as an independent risk factor for all-cause mortality:the Busselton health study. Sleep 31, 1079-1085.
94. Mathurin, P., Durand, F., Ganne, N., Mollo, J. L., Lebrec, D., Degott, C., et al. (1995). Ischemic hepatitis due to obstructive sleep apnea. Gastroen-terology 109, 1682-1684.
95. McCullough, A. J. (2004). The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin. Liver Dis. 8, 521-533, viii.
96. McCullough, A. J. (2006). Pathophys-iology of nonalcoholic steatohep-atitis. J. Clin. Gastroenterol. 40, S17-S29.
97. Mishra, P., Nugent, C., Afendy, A., Bai, C., Bhatia, P., Afendy, M., et al. (2008). Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver Int. 28, 1080-1086.
98. Myers, R. P., Pollett, A., Kirsch, R., Pomier-Layrargues, G., Beaton, M., Levstik, M., et al. (2012a). Controlled attenuation parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int. 32, 902-910.
99. Myers, R. P., Pomier-Layrargues, G., Kirsch, R., Pollett, A., Duarte-Rojo, A., Wong, D., et al. (2012b). Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55, 199-208.
100. Narkiewicz, K., Kato, M., Phillips, B. G., Pesek, C. A., Davison, D. E., and Somers, V. K. (1999). Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100, 2332-2335.
101. Narkiewicz, K., van de Borne, P. J., Coo-ley, R. L., Dyken, M. E., and Somers, V. K. (1998). Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98, 772-776.
102. Nath, B., and Szabo, G. (2012). Hypoxia and hypoxia inducible factors: diverse roles in liver diseases. Hepatology 55, 622-633.
103. Neuschwander-Tetri, B. A. (2010). Hepatic lipotoxicity and the patho-genesis of nonalcoholic steatohep-atitis: the central role of nontriglyc-eride fatty acid metabolites. Hepatol-ogy 52, 774-788.
104. Nomura, H., Kashiwagi, S., Hayashi, J., Kajiyama, W., Tani, S., and Goto, M. (1988). Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn. J. Med. 27, 142-149.
105. Norman, D., Bardwell, W. A., Arose-mena, F., Nelesen, R., Mills, P. J., Loredo, J. S., et al. (2008). Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 31, 121-126.
106. Novitskiy, G., Potter, J. J., Rennie-Tankersley, L., and Mezey, E. (2004). Identification of a novel NF-kappaB-binding site with regulation of the murine alpha2(I) collagen promoter. J. Biol. Chem. 279, 15639-15644.
107. Novitskiy, G., Potter, J. J., Wang, L., and Mezey, E. (2006). Influences of reactive oxygen species and nitric oxide on hepatic fibrogenesis. Liver Int. 26, 1248-1257.
108. Oliveira, C. P., Faintuch, J., Rascovski, A., Furuya, C. K. Jr., Bastos, M. S., Matsuda, M., et al. (2005). Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) - preliminary findings. Obes. Surg. 15, 502-505.
109. Patel, K. D., Abeysekera, K. W., Mar-lais, M., McPhail, M. J., Thomas, H. C., Fitzpatrick, J. A., et al. (2011). Recent advances in imaging hepatic fibrosis and steatosis. Expert Rev. Gastroenterol. Hepatol. 5, 91-104.
110. Peng, Y. J., Yuan, G., Ramakrishnan, D., Sharma, S. D., Bosch-Marce, M., Kumar, G. K., et al. (2006). Heterozygous HIF-1{alpha} deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J. Physiol. (Lond.) 577, 705-716.
111. Polotsky, V. Y., Li, J., Punjabi, N. M., Rubin, A. E., Smith, P. L., Schwartz, A. R., et al. (2003). Intermittent hypoxia increases insulin resistance in genetically obese mice. J. Physiol. (Lond.) 552, 253-264.
112. Polotsky, V. Y., Patil, S. P., Savransky, V., Laffan, A., Fonti, S., Frame, L. A., et al. (2009). Obstructive sleep apnea, insulin resistance, and steatohepati-tis in severe obesity. Am. J. Respir. Crit. Care Med. 179, 228-234.
113. Polotsky, V. Y., Rubin, A. E., Balbir, A., Dean, T., Smith, P. L., Schwartz, A. R., et al. (2006). Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleepinthe C57BL/6J mouse. Sleep Med. 7, 7-16.
114. Postic, C., Dentin, R., Denechaud, P. D., and Girard, J. (2007). ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annu. Rev. Nutr. 27, 179-192.
115. Poynard, T., Lassailly, G., Diaz, E., Clement, K., Caiazzo, R., Tord-jman, J., et al. (2012). Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashT-est in patients with severe obesity: meta analysis of individual patient data. PLoS ONE 7, e30325. doi:10.1371/journal.pone.0030325
116. Prabhakar, N. R., Dick, T. E., Nanduri, J., and Kumar, G. K. (2007). Systemic, cellular and molecular analysis of chemoreflex-mediated sympa-thoexcitation by chronic intermittent hypoxia. Exp. Physiol. 92, 39-44.
117. Prabhakar, N. R., and Kumar, G. K. (2010). Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxia. Respir. Physiol. Neurobiol. 174, 156-161.
118. Punjabi, N. M., Caffo, B. S., Goodwin, J. L., Gottlieb, D. J., Newman, A. B., O'Connor, G. T., et al. (2009). Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 6, e1000132. doi:10.1371/journal.pmed.1000132
119. Punjabi,N. M., Sorkin,J. D., Katzel, L. I., Goldberg, A. P., Schwartz, A. R., and Smith, P. L. (2002). Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am. J. Respir. Crit. Care. Med. 165, 677-682.
120. Qu, A., Taylor, M., Xue, X., Mat-subara, T., Metzger, D., Chambon, P., et al. (2011). Hypoxia-inducible transcription factor 2 alpha promotes steatohepatitis through augmenting lipid accumulation,inflam-mation, and fibrosis. Hepatology 54, 472-483.
121. Rankin, E. B., Higgins, D. F., Walisser, J. A., Johnson, R. S., Bradfield, C. A., and Haase, V. H. (2005). Inactiva-tion of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Mol. Cell. Biol. 25, 3163-3172.
122. Rankin, E. B., Rha, J., Selak, M. A., Unger, T. L., Keith, B., Liu, Q., et al. (2009). Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol. Cell. Biol. 29, 4527-4538.
123. Reinke, C., Bevans-Fonti, S., Drager, L. F., Shin, M. K., and Polotsky, V. Y. (2011a). Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J. Appl. Physiol. 111, 881-890.
124. Reinke, C., Bevans-Fonti, S., Grigoryev, D. N., Drager, L. F., Myers, A. C., Wise, R. A., et al. (2011b). Chronic intermittent hypoxia induces lung growth in adult mice. Am. J. Physiol. Lung Cell Mol. Physiol. 300, L266- L273.
125. Robertson, G., Leclercq, I., and Farrell, G. C. (2001). Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G1135-G1139.
126. Robinson, G. V., Pepperell, J. C., Segal, H. C., Davies, R. J., and Stradling, J. R. (2004). Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59, 777-782.
127. Saibara, T., Nozaki, Y., Nemoto, Y., Ono, M., and Onishi, S. (2002). Low socioeconomic status and coronary artery disease. Lancet 359, 980.
128. Samuel, V. T., Liu, Z. X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., et al. (2004). Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279, 32345-32353.
129. Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., et al. (2010). Pioglita-zone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675-1685.
130. Savage, D. B., Petersen, K. F., and Shul-man, G. I. (2007). Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87, 507-520.
131. Savransky, V., Bevans, S., Nanayakkara, A., Li, J., Smith, P. L., Torben-son, M. S., et al. (2007a). Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am. J. Phys-iol. Gastrointest. Liver Physiol. 293, G871-G877.
132. Savransky, V., Nanayakkara, A., Li, J., Bevans, S., Smith, P. L., Rodriguez, A., et al. (2007b). Chronic intermittent hypoxia induces atherosclerosis. Am. J. Respir. Crit. Care Med. 175, 1290-1297.
133. Savransky, V., Nanayakkara, A., Vivero, A., Li, J., Bevans, S., Smith, P. L., et al. (2007c). Chronic intermittent hypoxia predisposes to liver injury. Hepatology 45, 1007-1013.
134. Schneider, M., Van, G. K., Fraisl, P., Kiss, J., Aragones, J., Mazzone, M., et al. (2010). Loss or silencing of the PHD1 prolyl hydroxy-lase protects livers of mice against ischemia/reperfusion injury. Gas-troenterology 138, 1143-1154.
135. Scortegagna, M., Cataisson, C., Martin, R. J., Hicklin, D. J., Schreiber, R. D., Yuspa, S. H., et al. (2008). HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood 111, 3343-3354.
136. Seki, S., Kitada, T., and Sakaguchi, H. (2005). Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol. Res. 33, 132-134.
137. Semenza,G.L. (2007). Lifewith oxygen. Science 318, 62-64.
138. Semenza, G. L., and Prabhakar, N. R. (2007). HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. Antioxid Redox Signal 9, 1391-1396.
139. Sharma, S. K., Agrawal, S., Damodaran, D., Sreenivas,V., Kadhiravan,T., Lak-shmy, R., et al. (2011). CPAP for the metabolic syndromeinpatients with obstructive sleep apnea. N. Engl. J. Med. 365, 2277-2286.
140. Shimomura, I. ,Bashmakov, Y.,and Horton, J. D. (1999a). Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274, 30028-30032.
141. Shimomura, I., Bashmakov, Y., Ike-moto, S., Horton, J. D., Brown, M. S., and Goldstein, J. L. (1999b). Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A. 96, 13656-13661.
142. Shimomura,I.,Hammer,R.E.,Richard-son, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., et al. (1998). Insulin resistance and diabetes mel-litus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12, 3182-3194.
143. Shpirer, I., Copel, L., Broide, E., and Elizur, A. (2010). Continuous positive airway pressure improves sleep apnea associated fatty liver. Lung 188, 301-307.
144. Singh, H., Pollock, R., Uhanova, J., Kryger, M., Hawkins, K., and Minuk, G. Y. (2005). Symptoms of obstructive sleep apneain patientswith nonalcoholic fatty liver disease. Dig. Dis. Sci. 50, 2338-2343.
145. Sinha, S., Perdomo, G., Brown, N. F., and O'Doherty, R. M. (2004). Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B. J. Biol. Chem. 279, 41294-41301.
146. Sivam, S., Phillips, C. L., Trenell, M. I., Yee, B. J., Liu, P. Y., Wong, K. K., et al. (2012). Effects of 8 weeks of CPAP on abdominal adiposity in obstructive sleep apnoea. Eur. Respir. J. 40, 913-918.
147. Somers, V. K., Dyken, M. E., Clary, M. P., and Abboud, F. M. (1995). Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest. 96, 1897-1904.
148. Somers,V. K., Mark, A. L., Zavala, D. C., and Abboud,F. M. (1989). Contrasting effects of hypoxia and hypercap-nia on ventilation and sympathetic activity in humans. J. Appl. Physiol. 67, 2101-2106.
149. Springer, F., MacHann, J., Claussen, C. D., Schick, F., and Schwenzer, N. F. (2010). Liver fat content determined by magnetic resonance imaging and spectroscopy. World J. Gastroenterol. 16, 1560-1566.
150. Tanne, F., Gagnadoux, F., Chazouilleres, O., Fleury, B., Wendum, D., Las-nier, E., et al. (2005). Chronic liver injury during obstructive sleep apnea. Hepatology 41, 1290-1296.
151. Tatsumi, K., and Saibara, T. (2005). Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepa-tol. Res. 33, 100-104.
152. Taylor,C.T.,and Cummins,E.P.(2009). The role of NF-kappaB in hypoxia-induced gene expression. Ann. N. Y. Acad. Sci. 1177, 178-184.
153. Tilg, H., and Moschen, A. R. (2010). Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepa-tology 52, 1836-1846.
154. Torres, D. M., and Harrison, S. A. (2008). Diagnosis and therapy of nonalcoholic steatohepatitis. Gas-troenterology 134, 1682-1698.
155. Trakada, G., Gogos, C., Tsiamita, M., Siagris, D., Goumas, P., and Spiropoulos, K. (2004). A case of ischemic hepatitis. Sleep Breath 8, 155-159.
156. Tufik, S., Santos-Silva, R., Taddei, J. A., and Bittencourt, L. R. (2010). Obstructive sleep apnea syndrome in the Sao Paulo Epidemi-ologic Sleep Study. Sleep Med. 11, 441-446.
157. Vgontzas, A. N., Papanicolaou, D. A., Bixler,E. O., Hopper, K., Lotsikas, A., Lin, H. M., et al. (2000). Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J. Clin. Endocrinol. Metab. 85, 1151-1158.
158. Vuppalanchi, R., and Chalasani, N. (2009). Nonalcoholic fatty liver disease and nonalcoholic steatohep-atitis: selected practical issues in their evaluation and management. Hepatology 49, 306-317.
159. Walmsley, S. R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R. S., Cramer, T., et al. (2005). Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J. Exp. Med. 201, 105-115.
160. Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., and Mohsenin, V. (2005). Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 353, 2034-2041.
161. Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., et al. (2007). Inhibiting triglyceride synthesis improves hepatic steato-sis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45, 1366-1374.
162. Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., et al. (2008). Diacylglycerol acyltran-ferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis. Hepa-tology 47, 625-635.
163. Young, T., Finn, L., Peppard, P. E., Szklo-Coxe, M., Austin, D., Nieto, F. J., et al. (2008). Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31, 1071-1078.
164. Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., and Badr, S. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328, 1230-1235.
165. Young, T., Peppard, P. E., and Gottlieb, D. J. (2002). Epidemiology of obstructive sleep apnea: a population health perspective.Am. J. Respir. Crit. Care Med. 165, 1217-1239.
166. Zechner, R., Kienesberger, P. C., Haem-merle, G., Zimmermann, R., and Lass, A. (2009). Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J. Lipid Res. 50, 3-21.